"We are excited to receive this Phase II grant from NIH-NIEHS, which underscores the importance of our research in environmental health," said John Michalek, CEO of Zebra Analytix. "This funding will enable us to further develop our innovative monitoring system and bring us closer to our goal of providing reliable and efficient solutions for toxic gas detection."
The autonomous monitor being developed by Zebra Analytix leverages state-of-the-art sensor and chromatography column technology with advanced data analytics to provide accurate and timely detection of toxic gases in various environments. By integrating cutting-edge hardware with sophisticated algorithms, the system will offer unparalleled sensitivity and selectivity, allowing for early detection and mitigation of potential hazards.
About Zebra Analytix
Zebra Analytix was established to develop and commercialize miniature gas chromatography (GC) systems based on microelectromechanical systems (MEMS) innovation. The patent-protected technology offers microfabricated chips capable of multi-channel separations. Advantages include vastly decreased instrument size, lower cost, versatility, portability, and speed to results. For more information, please visit zebraanalytix.com
About VIC Technology Venture Development
VIC’s unique investment model sources innovation directly from universities across the nation, offering funding to form new start-up companies and advance these technologies. In addition to the initial capital, VIC provides its portfolio companies with business and scientific resources, including interim management, accounting, marketing, engineering support and more. For more information, please visit victech.com